Kyowa Kirin   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Tokyo Japan (1949)

Organization Overview

First Clinical Trial
2002
NCT00456794
First Marketed Drug
1997
toremifene (fareston)
First NDA Approval
1997
toremifene (fareston)
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kirin Holdings Company, Limited | Kyowa Kirin | KYOWA KIRIN | Kyowa Kirin Korea Co., Ltd. | Kyowa Kirin Pharmaceutical Development, Inc. | Kyowa Kirin Pharmaceutical International Ltd.